CALCOCO2 and chronic hepatitis B virus infection: We investigated the effects of NDP52 on HBV in vivo in a mouse model for chronic hepatitis B. HBV infection was established by transduction of mice with recombinant adeno-associated virus HBV (AAVHBV)37.